AMSTERDAM MOLECULAR THERAPEUTICS (AMT) BV – Trademark Portfolio

Entity Type: 16

AMSTERDAM MOLECULAR THERAPEUTICS (AMT) BV holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. The owner is based in Amsterdam.

Meibergdreef 61

Amsterdam NL-1105BA , NL

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

GLYBERA
GLYBERA
Cancelled 2007

Trademark Classifications

AMSTERDAM MOLECULAR THERAPEUTICS (AMT) BV's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does AMSTERDAM MOLECULAR THERAPEUTICS (AMT) BV have?

AMSTERDAM MOLECULAR THERAPEUTICS (AMT) BV has 1 U.S. trademark filed with the USPTO.

What trademark classes does AMSTERDAM MOLECULAR THERAPEUTICS (AMT) BV file in?

AMSTERDAM MOLECULAR THERAPEUTICS (AMT) BV files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is AMSTERDAM MOLECULAR THERAPEUTICS (AMT) BV's trademark registration success rate?

AMSTERDAM MOLECULAR THERAPEUTICS (AMT) BV has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.